Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05812131 · ClinicalTrials.gov registry record · NA
COPEWeb Training for Providers
A NA study of PTSD and Substance Use Disorders, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT05812131: Recruiting NA study of PTSD and Substance Use Disorders, sponsored by VA Office of Research and Development.
NCT05812131 is a NA study of PTSD and Substance Use Disorders that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 248 participants, below the 300-participant average among 154 other PTSD trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05812131, a NA study of PTSD and Substance Use Disorders, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
PTSD and substance use disorders (SUD) are two of the most common and debilitating mental health conditions afflicting military Veterans. PTSD and SUD frequently co-occur and are associated with poorer treatment outcomes. The investigators' team developed a trauma-focused intervention, Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE), which is identified by the VA as a gold standard of behavioral healthcare and was designated as a first-line treatment in the 2025 APA Clinical Practice Guideline for PTSD. However, a critical barrier to ensuring that Veterans with co-occurring PTSD/SUD receive evidence-based treatment is a lack of provider training. This project directly addresses this critical gap by developing a new web-based training program for providers (COPEWeb).
Primary Outcome
The CSUQ is a 19-item Likert-type (7-point \[strongly agree to strongly disagree\]) questionnaire that provides an overall usability satisfaction score along with subscales that measure program usefulness, information quality, and interface quality. The CSUQ measure and subscales have good reliability, sensitivity, and validity.
Conditions Studied
Interventions
- BEHAVIORAL COPEWeb online training
- BEHAVIORAL COPE In Person
Study Locations (1)
South Carolina
- Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-04-05 |
| Phase | NA |
What NCT05812131 shows while recruiting
NCT05812131 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 300-participant average among 154 other PTSD trials with a reported enrollment target (17% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which COPEWeb online training is the first listed.
NCT05812131 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05812131 about?
NCT05812131 is a clinical study titled "COPEWeb Training for Providers". PTSD and substance use disorders (SUD) are two of the most common and debilitating mental health conditions afflicting military Veterans. PTSD and SUD frequently co-occur and are associated with poorer treatment outcomes. The investigators' team developed a trauma-focused intervention, Concurrent Tr...
What is the current status of trial NCT05812131?
This trial is currently recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2025-05-01. Estimated completion is 2027-04-05.
What conditions does trial NCT05812131 study?
This clinical trial studies the following conditions: PTSD, Substance Use Disorders.
What interventions are being tested in trial NCT05812131?
The interventions under investigation include: COPEWeb online training (BEHAVIORAL), COPE In Person (BEHAVIORAL).
Who is sponsoring clinical trial NCT05812131?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05812131 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05812131's enrollment target sits among peer trials
248 22nd of 154 higher than 133 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI